Unknown

Dataset Information

0

Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment.


ABSTRACT: The Hedgehog (Hh) pathway, containing the Patched (PTCH) and Smoothened (SMO) multitransmembrane proteins, is the main regulator of vertebrate embryonic development. A non-canonical Hh pathway was recently observed in numerous types of solid cancers and hematological malignancies. Although acute myeloid leukemia (AML) is a common and lethal myeloid malignancy, the chemotherapy for AML has not changed in the last three decades. The Hh pathway and other intracellular signaling pathways are important for the tumor cells' cycle or therapeutic resistance of AML cells. In this article, we will review the current trends in Hh pathway inhibitors for treating AML.

SUBMITTER: Terao T 

PROVIDER: S-EPMC6523210 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment.

Terao Toshiki T   Minami Yosuke Y  

Cells 20190403 4


The Hedgehog (Hh) pathway, containing the Patched (PTCH) and Smoothened (SMO) multitransmembrane proteins, is the main regulator of vertebrate embryonic development. A non-canonical Hh pathway was recently observed in numerous types of solid cancers and hematological malignancies. Although acute myeloid leukemia (AML) is a common and lethal myeloid malignancy, the chemotherapy for AML has not changed in the last three decades. The Hh pathway and other intracellular signaling pathways are importa  ...[more]

Similar Datasets

| S-EPMC8447269 | biostudies-literature
| S-EPMC5267446 | biostudies-literature
| S-EPMC6606342 | biostudies-literature
| S-EPMC8073742 | biostudies-literature
| S-EPMC8592969 | biostudies-literature
| S-EPMC4502679 | biostudies-literature
| S-EPMC5312311 | biostudies-literature
| S-EPMC5576374 | biostudies-literature
| S-EPMC7737216 | biostudies-literature
| S-EPMC4925018 | biostudies-literature